en
Scientific article
Open access
English

Tocilizumab in the treatment of rheumatoid arthritis: a cost-effectiveness analysis in the UK

Published inPharmacoEconomics, vol. 32, no. 8, p. 775-787
Publication date2014
Abstract

Since receiving a positive recommendation in England, Wales and Scotland, tocilizumab (TCZ) is one of the options available to clinicians for the treatment of rheumatoid arthritis (RA) patients in the UK.

Citation (ISO format)
DIAMANTOPOULOS, Alex et al. Tocilizumab in the treatment of rheumatoid arthritis: a cost-effectiveness analysis in the UK. In: PharmacoEconomics, 2014, vol. 32, n° 8, p. 775–787. doi: 10.1007/s40273-014-0165-7
Main files (1)
Article (Published version)
accessLevelPublic
Identifiers
ISSN of the journal1179-2027
447views
436downloads

Technical informations

Creation01/27/2015 3:35:00 PM
First validation01/27/2015 3:35:00 PM
Update time03/14/2023 10:45:53 PM
Status update03/14/2023 10:45:53 PM
Last indexation01/16/2024 4:28:04 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack